Aspirion CEO Nick Giannasi said in a Dec. 18 news release that Boost Healthcare’s expertise in zero-balance review, payment variance, denials management, and No Surprises Act compliance “strengthens Aspirion’s ability to transform healthcare financial operations.”
“By combining Boost’s deep expertise with our technology and AI, we are exponentially scaling our capacity to secure the rightful reimbursement for healthcare providers,” Mr. Giannasi said.
The latest acquisition marks Aspirion’s seventh in six years, according to the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.